Results 211 to 220 of about 79,610 (281)

Emerging Technologies for Investigating Food Consumer Behavior: A Systematic Review. [PDF]

Compr Rev Food Sci Food Saf
Kechri K, Kleisiari C, Kyrgiakos LS, Vasileiou M, Tosiliani DD, Angelopoulos V, Kleftodimos G, Vlontzos G.   +7 more
europepmc   +1 more source

Artificial intelligence in preclinical epilepsy research: Current state, potential, and challenges

Epilepsia Open, EarlyView.
Abstract Preclinical translational epilepsy research uses animal models to better understand the mechanisms underlying epilepsy and its comorbidities, as well as to analyze and develop potential treatments that may mitigate this neurological disorder and its associated conditions. Artificial intelligence (AI) has emerged as a transformative tool across
Jesús Servando Medel‐Matus, Cesar Santana‐Gomez, Ruby G. Escalante, Dominique Duncan, Pedro F. Viana, Giulia Sofia Cereda, Naoto Kuroda, Aristea S. Galanopoulou   +7 more
wiley   +1 more source

The dilemma of sweet temptation: How sugar perception confusion in sweetened beverages shapes consumer avoidance behavior. [PDF]

PLoS One
Li Q, Yang X, Bai X, Zhang Y, Li Q, Li Y.   +5 more
europepmc   +1 more source

Status epilepticus: Updates on mechanisms and treatments

Epilepsia Open, EarlyView.
Abstract Status epilepticus (SE) consists of prolonged, self‐sustaining seizures and is a common neurological emergency that causes respiratory compromise and neuronal injury. Without prompt treatment, the seizures can become resistant to benzodiazepines, leading to the progressive evolution of established, refractory, and super‐refractory SE.
Suchitra Joshi, Jaideep Kapur
wiley   +1 more source

The effects of human training data (HTD) explanation on purchase intention for artificial intelligence (AI) technologies. [PDF]

PLoS One
Dharmaputri SK, Nyilasy G, Nagpal A, Lei J.   +3 more
europepmc   +1 more source

Ketogenic diet for infantile epileptic spasms

Epilepsia Open, EarlyView.
Abstract Approximately half of all cases of Infantile Epileptic Spasms Syndrome (IESS) do not respond to vigabatrin and hormonal therapies. There is no clear consensus as to the second‐line therapy for IESS. Ketogenic diet (KD) has emerged as an effective treatment for certain drug‐resistant epilepsies and in many cases of IESS.
Morris H. Scantlebury, Anamika Choudhary, Andy Cheuk‐Him Ng, Cezar Gavrilovici   +3 more
wiley   +1 more source

Odor repellency and neuronal responses of commercial products towards Anopheles mosquitoes. [PDF]

Malar J
Nguyen MN, Johnson JM, Olaleye I, Potter CJ.   +3 more
europepmc   +1 more source

How to report neurotechnology and artificial intelligence studies in epilepsy: Peer‐review‐inspired recommendations

Epilepsia Open, EarlyView.
Abstract Objective The integration of neurotechnology and artificial intelligence (AI) in epilepsy research has led to significant advancements in diagnosis, monitoring, and treatment. However, the impact of these innovations is often diminished by inadequate and inaccurate reporting, limiting their reproducibility and implementation.
Pedro F. Viana, Matthew McWilliam, Andrea Biondi, Jesus Servando Medel‐Matus, Naoto Kuroda, Giulia Sofia Cereda, Aristea S. Galanopoulou   +6 more
wiley   +1 more source

Memantine and graded motor imagery for complex regional pain syndrome (MEMOIR): study protocol and statistical analysis plan for a decentralised, 2 × 2 factorial randomised trial. [PDF]

Trials
Ferraro MC, Gilanyi YL, Visser EJ, McLachlan AJ, Moseley GL, Wand BM, O'Connell NE, Lee H, Lotze M, Church J, Goodall S, Herbert RD, Lamb SE, Gustin SM, Cashin AG, McAuley JH.   +15 more
europepmc   +1 more source

Cost‐effectiveness of fenfluramine as add‐on treatment in the management of Dravet Syndrome: A real‐world multicenter study

Epilepsia Open, EarlyView.
Abstract Objective Dravet syndrome (DS) is a rare disease with a high clinical and socioeconomic impact on patients, society, and the healthcare system. The recent approval of therapies such as fenfluramine (FFA) has transformed the treatment landscape; however, data on their cost‐effectiveness are still scarce. This study evaluates the real‐world cost‐
Paolo A. Cortesi, Carla Fornari, Alessandra Boncristiano, Rita Facchetti, Simona Balestrini, Viola Doccini, Nicola Specchio, Nicola Pietrafusa, Marina Trivisano, Francesca Darra, Alberto Cossu, Domenica I. Battaglia, Michela Quintiliani, Maria L. Gambardella, Lorenzo G. Mantovani, Renzo Guerrini   +15 more
wiley   +1 more source